Technical Analysis for CPH - Cipher Pharmaceuticals Inc.

Grade Last Price % Change Price Change
B 8.900 -3.99% -0.370
CPH closed down 3.99 percent on Thursday, March 28, 2024, on 1.35 times normal volume.
1 Watcher
Watchlist Portfolio

Trend Table & Recent EOD Trading Signals

ADX Long Term Intermediate Term Short Term
Strong Up Up Flat

Date Alert Name Type % Chg
Wide Bands Range Expansion 0.00%
Overbought Stochastic Strength 0.00%
Gapped Down Weakness 0.00%
Bearish Engulfing Bearish -3.99%
Slingshot Bullish Bullish Swing Setup -3.99%
NR7 Range Contraction -3.99%
Upper Bollinger Band Walk Strength -3.99%
Wide Bands Range Expansion -3.99%
Overbought Stochastic Strength -3.99%
Shooting Star Candlestick Bearish -6.32%

   Recent Intraday Alerts

Alert Time
Fell Below 10 DMA about 18 hours ago
Down 1 ATR about 21 hours ago
10 DMA Support about 21 hours ago
Down 5% about 21 hours ago
2x Volume Pace about 21 hours ago

Get a Trading Sidekick!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.

Profile

Cipher Pharmaceuticals Inc. Description

Cipher Pharmaceuticals Inc. is a specialty pharmaceutical dermatology company. The Company has a portfolio of commercial and late-stage products. It operates in the specialty pharmaceuticals segment. It acquires products and compounds for treatment of various medical needs. Its commercial product portfolio includes ABSORICA; SITAVIG; NUVAIL; BIONECT; CLN8; INOVA; PRO:12 MOUSSE; AL12; LOTION UMECTA; ACLARO; EPURIS; VANIQA; ACTIKERALL; BETEFLAM; LIPOFEN; CONZIP, and DURELA. Its products treat indications, such as severe nodular acne, recurrent herpes labialis, nail dystrophy, dermal ulcers, mild/moderate onychomycosis, acne, dry skin, keratosis, hyperpigmentation, hyperkeratotic actinic keratosis and high cholesterol. Its pipeline of late-stage products includes DERMADEXIN, BETEFLAM PATCH, SITAVIG, PRURIDEXIN, OZENOXACIN, CF101 for plaque psoriasis, CF101 for rheumatoid arthritis, ASF-1096 and NANOLIPOLEE-007. It operates in Canada and the United States.


Classification

Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Keywords: Medicine Pharma Pipe Pharmaceutical Pipeline RTT Skin Pharmaceuticals IPO Organ Systems Arthritis Ulcer Dermatology Nail Psoriasis Acne Actinic Keratosis Herpes Labialis Keratosis Onychomycosis Rheumatoid Arthritis

Is CPH a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 9.98
52 Week Low 3.11
Average Volume 43,968
200-Day Moving Average 5.229
50-Day Moving Average 7.119
20-Day Moving Average 8.005
10-Day Moving Average 8.861
Average True Range 0.471
RSI (14) 65.40
ADX 37.57
+DI 35.772
-DI 17.066
Chandelier Exit (Long, 3 ATRs) 8.569
Chandelier Exit (Short, 3 ATRs) 8.082
Upper Bollinger Bands 9.846
Lower Bollinger Band 6.164
Percent B (%b) 0.74
BandWidth 45.994
MACD Line 0.626
MACD Signal Line 0.517
MACD Histogram 0.1086
Fundamentals Value
Market Cap 240.56 Million
Num Shares 27 Million
EPS 0.28
Price-to-Earnings (P/E) Ratio 31.45
Price-to-Sales 0.85
Price-to-Book 0.55
PEG Ratio 0.00
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 9.905
Resistance 3 (R3) 9.970 9.700 9.738
Resistance 2 (R2) 9.700 9.444 9.668 9.682
Resistance 1 (R1) 9.300 9.286 9.165 9.235 9.626
Pivot Point 9.030 9.030 8.963 8.998 9.030
Support 1 (S1) 8.630 8.774 8.495 8.565 8.174
Support 2 (S2) 8.360 8.616 8.328 8.118
Support 3 (S3) 7.960 8.360 8.063
Support 4 (S4) 7.895